{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:24:37Z","timestamp":1790753077937,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T00:00:00Z","timestamp":1461196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","aaojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.ophtha.2016.04.026","type":"journal-article","created":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T22:28:10Z","timestamp":1462487290000},"page":"1685-1694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"title":["Six-Month Intraocular Pressure Reduction with a Topical Bimatoprost Ocular Insert"],"prefix":"10.1016","volume":"123","clinical-trial-number":[{"clinical-trial-number":"nct01915940","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"James D.","family":"Brandt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8868-4894","authenticated-orcid":false,"given":"Kenneth","family":"Sall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey","family":"DuBiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Benza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yair","family":"Alster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles P.","family":"Semba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Budenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Flowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quang","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wirta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2016.04.026_bib1","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ajo.2005.04.051","article-title":"Persistence and adherence with topical glaucoma therapy","volume":"140","author":"Nordstrom","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.04.026_bib2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ophtha.2016.04.026_bib3","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.survophthal.2008.08.002","article-title":"Adherence and persistence with glaucoma therapy","volume":"53","author":"Schwartz","year":"2008","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.04.026_bib4","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.ophtha.2015.03.026","article-title":"The most common barriers to glaucoma medication adherence","volume":"122","author":"Newman-Casey","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2016.04.026_bib5","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1016\/j.ophtha.2011.05.013","article-title":"The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity","volume":"118","author":"Sleath","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2016.04.026_bib6","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0161-6420(01)00584-X","article-title":"Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP","volume":"108","author":"Brandt","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2016.04.026_bib7","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","volume":"120","author":"Kass","year":"2002","journal-title":"Arch Ophthalmol"},{"issue":"Suppl 4","key":"10.1016\/j.ophtha.2016.04.026_bib8","doi-asserted-by":"crossref","first-page":"S361","DOI":"10.1016\/S0039-6257(01)00219-3","article-title":"Six-month comparison of bimatoprost once-daily and twice-daily with timolol-twice daily in patients with elevated intraocular pressure","volume":"45","author":"Sherwood","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.04.026_bib9","unstructured":"Allergan, Inc. Lumigan (bimatoprost ophthalmic solution) 0.01%. Full prescribing information. Available at: http:\/\/www.allergan.com\/assets\/pdf\/lumigan_pi.pdf. Accessed December 7,\u00a02015."},{"key":"10.1016\/j.ophtha.2016.04.026_bib10","unstructured":"Alcon, Inc. Travatan-Z (travoprost ophthalmic solution) 0.004%. Full prescribing information. Available at: http:\/\/www.myglaucomasupport.com\/travatan-z-solution.shtml?utm_source=travatanz.com&utm_medium=Redirect&utm_campaign=travatanz.com. Accessed December 7,\u00a02015."},{"key":"10.1016\/j.ophtha.2016.04.026_bib11","unstructured":"Pfizer, Inc. Xalatan (latanoprost ophthalmic solution) 0.005%. Full prescribing information. Available at: http:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=613. Accessed December 7,\u00a02015."},{"key":"10.1016\/j.ophtha.2016.04.026_bib12","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/02713689808951229","article-title":"Latanoprost twice daily is less effective than once daily: indication of receptor subsensitivity?","volume":"17","author":"Linden","year":"1998","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ophtha.2016.04.026_bib13","unstructured":"Ocular Therapeutix, Inc. Ocular Innovation Summit, November 16, 2014, Chicago, IL. Available at: http:\/\/ois.net\/\/wp-content\/uploads\/2014\/10\/Ocular-Therapeutix.pdf. Accessed December 7,\u00a02015."},{"key":"10.1016\/j.ophtha.2016.04.026_bib14","unstructured":"MATI Therapeutics, Inc. Ocular Innovation Summit, November 16, 2014, Chicago, IL. Available at: http:\/\/ois.net\/\/wp-content\/uploads\/2014\/10\/Mati-Therapeutics.pdf. Accessed December 7,\u00a02015."},{"key":"10.1016\/j.ophtha.2016.04.026_bib15","first-page":"1008","article-title":"Pilocarpine ocular inserts","volume":"15","author":"Bensinger","year":"1976","journal-title":"Invest Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.04.026_bib16","unstructured":"United States Food and Drug Administration. Ocusert Pilo-20 (pilocarpine) 5 mg. Available at: http:\/\/www.accessdata.fda.gov\/scripts\/cder\/drugsatfda\/index.cfm?fuseaction=Search.DrugDetails. Accessed July 17,\u00a02015."}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642016302032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642016302032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T20:41:32Z","timestamp":1666557692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642016302032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0161642016302032"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2016.04.026","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Six-Month Intraocular Pressure Reduction with a Topical Bimatoprost Ocular Insert","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2016.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American Academy of OphthalmologyThis is an open access article under the CC BY-NC-ND license (<inter-ref xlink: href=http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/>http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/<\/inter-ref>).","name":"copyright","label":"Copyright"}]}}